Today: 1 July 2026
Browse Category

NYSE:PLTR 27 April 2026 - 12 June 2026

Palantir Stock Slides as AI Growth Story Meets Governance and UK Contract Scrutiny

Palantir Stock Slides as AI Growth Story Meets Governance and UK Contract Scrutiny

Palantir Technologies Inc. shares fell Friday, closing at $127.99, down 2.36%, as investors weighed renewed political and governance pressure against the company’s still-rapid artificial intelligence growth story. The move left PLTR near the lower end of its day’s trading range and extended pressure on a stock that remains richly valued by conventional measures, including a trailing price-to-earnings ratio, or P/E, of about 147; P/E compares a company’s share price with its profit per share. The latest pressure was partly technical. GuruFocus, via TradingView, said Palantir had failed to hold a breakout above a descending trendline and had run into resistance near its 200-day moving average, a widely watched line showing a stock’s average price over roughly the past 200 trading sessions. The report identified support near $126.50, making that level important for short-term traders watching whether buyers step in or the selloff deepens.
12 June 2026
·
Palantir CEO Karp takes aim at AI spend by Anthropic, OpenAI

Palantir CEO Karp takes aim at AI spend by Anthropic, OpenAI

Palantir CEO Alex Karp on CNBC Wednesday criticized frontier AI labs, saying many enterprise clients are privately dissatisfied with those companies. Karp told CNBC’s Sara Eisen that discontent isn’t just limited to everyday users. He said most of the Anthropic projects discussed in public are “running on Palantir.” Corporate AI buyers are starting to set real budgets, not just run pilots. Business Insider said Wednesday that OpenAI, Anthropic and GitHub are steering more customers to token-based billing, where users pay for the text AI models handle. Coinbase and Walmart added usage caps, and Amazon dropped its internal token leaderboard.
10 June 2026
·····
Palantir’s $200 Target Meets Doubts on AI Growth

Palantir’s $200 Target Meets Doubts on AI Growth

Palantir Technologies stock moved just 0.15% higher to $135.73 in Monday afternoon trades, with little change after a tough stretch last week. The market cap was about $349 billion. Investors kept selling pressure on the shares as they tried to gauge new bullish opinions on the company’s AI software against a valuation that offers little margin for error. Arguments around Palantir have picked up as the company sheds its image as only a defense-data play with an AI tag. Q1 numbers showed strong gains in both government and commercial sales. Now, after dropping over 20% this year, the question is back—can the stock recover its past pace? Market writers are raising that issue once more.
8 June 2026
···
Palantir Stock Dips Despite Google AI News

Palantir Stock Dips Despite Google AI News

Palantir Technologies shares slipped Thursday, reversing an earlier gain. The data software company had rallied after news at its AIPCon customer event, where Palantir announced a bigger Google Cloud partnership and multiple new commercial deals. The stock traded at $140.89 in the latest quote, off 0.9%. It started the session at $145.63 and touched $146.81 at its peak. That left it underperforming the SPDR S&P 500 ETF, which gained 0.4%. The Invesco QQQ Trust, which tracks the Nasdaq-100, was down 0.3%.
4 June 2026
···
Palantir’s $374 Billion Question Edges Back Into Focus

Palantir’s $374 Billion Question Edges Back Into Focus

Palantir shares dropped roughly 4% after the open in New York on Wednesday, with both bullish and bearish voices out in force as the debate grew over whether the AI software firm’s trajectory justifies its high price tag. The stock changed hands at $145.96 at 9:47 a.m. EDT, putting Palantir’s market cap near $374 billion. Palantir faces tough timing with its annual meeting scheduled for 10 a.m. EDT on Wednesday. Investors plan to vote on several shareholder proposals, including calls for human-rights reports on how Palantir products are used in defense and immigration. The board wants shareholders to vote down the proposals.
3 June 2026
···
Palantir gains premarket with AI stock catalyst eyed

Palantir gains premarket with AI stock catalyst eyed

Palantir Technologies climbed around 3.6% in quiet pre-market trade Monday, pushing its recent rally further as AI-related software names found buyers again. Shares traded at $162.14 as of 7:45 a.m. EDT. Palantir closed up 9.21% Friday at $156.54, after gaining 8.17% Thursday to $143.34. The move took place before the regular Nasdaq hours, which are 9:30 a.m. to 4 p.m. Eastern. Pre-market trading often sees prices shift on lower volume. Monday wasn’t on Nasdaq’s list of 2026 U.S. market holidays.
1 June 2026
···
Palantir Stock Rallies the Most in a Year as Another Test Nears

Palantir Stock Rallies the Most in a Year as Another Test Nears

Palantir Technologies finished Friday at $156.54, gaining 9.2% and logging its best session in over a year. The closing price pushed its market cap close to $402 billion, with a price-to-earnings ratio around 176, according to market data. Sunday trading isn’t an option. The New York Stock Exchange shuts down for the weekend, with normal hours from 9:30 a.m. to 4 p.m. Eastern on weekdays.
31 May 2026
····
Palantir Jumps 9% as AI Software Stocks Face Next Test

Palantir Jumps 9% as AI Software Stocks Face Next Test

Palantir Technologies Inc. shares climbed 9.2% to $156.54 on Friday, as the data-analytics stock rallied with software names and landed back in the AI spotlight. The gain extended a two-day jump, marking its best two-session stretch since April 2025, Dow Jones Market Data told Barron’s. AI bets helped software names after Snowflake posted results and Dell Technologies raised its AI outlook this week. Investors have been looking for cues on whether AI is boosting enterprise software makers or hurting them, and fresh updates gave bulls new fuel to buy into stocks linked to corporate AI budgets.
30 May 2026
··
Palantir Gets AI-Defense Boost, but Rally Faces Hurdle

Palantir Gets AI-Defense Boost, but Rally Faces Hurdle

Palantir Technologies Inc. was quoted at $143.34 late in premarket trade Friday, recovering more than 8% from Thursday’s close as buyers came back into artificial intelligence and defense-focused software stocks ahead of the U.S. session. Timing is key. U.S. stock futures barely moved after the main indexes put up fresh highs, with traders sticking to the AI trade and hoping for solid earnings. Investors also kept an eye on news out of the Middle East and inflation numbers. Nasdaq 100 futures saw little change as of 04:46 a.m. ET, according to Reuters.
29 May 2026
···
Palantir Technologies Stock Just Got an AI Forecast Boost. Why Investors Still Paused

Palantir’s AI run faces sticking point on Wall Street

Palantir Technologies shares ticked up on Tuesday, but a series of new investor comments pulled attention to the company’s valuation again. That comes after Palantir’s drop so far this year, which has been notable even in a rough year for software stocks. Palantir shares were recently up 0.8% at $137.98. That put the company’s market cap at roughly $354.7 billion. The stock is trading at a price-to-earnings ratio close to 155, still a lofty figure despite the recent dip.
26 May 2026
···
Palantir boosts outlook, but AI stock stays under watch

Palantir boosts outlook, but AI stock stays under watch

Palantir Technologies stock is starting the week down from where it was before last week, after a strong sales outlook failed to resolve the bulls-versus-bears debate around one of Wall Street’s battleground AI names. U.S. cash equities did not trade Sunday. Palantir ended Friday at $133.99, capping a volatile week that saw shares dip as low as $130.05 midweek. On Friday, Palantir moved between $132.29 and $135.64. Back on May 8, the stock closed higher at $137.80.
17 May 2026
··
Palantir’s AI Work in Ukraine Draws PLTR Into Human-Rights Firestorm

Palantir’s AI Work in Ukraine Draws PLTR Into Human-Rights Firestorm

Palantir Technologies Inc. came under renewed scrutiny from investors on Friday. A shareholder filing, which included signatories controlling no less than $336.1 billion in assets under management or advisement, threw its weight behind calls for an independent human-rights review of Palantir’s software. The move arrived as fresh focus fell on the company’s battlefield artificial intelligence tools in Ukraine, where its models are being used to process data and drive automated decision-making. Palantir’s annual meeting comes up June 3, with shareholders facing two proposals: one calling for expanded disclosure around defense due diligence, another for a human-rights impact assessment—a check on any actual or potential rights harms linked to the company’s technology. The board wants both measures voted down. It argues Palantir isn’t a data or surveillance firm, that it doesn’t trade in personal data, and points to legal and classification hurdles for sharing more information.
15 May 2026
···
Top AI Stocks To Watch Today: Nvidia, Microsoft, Broadcom, AMD, Palantir And Cerebras Face A Yield Test

Top AI Stocks To Watch Today: Nvidia, Microsoft, Broadcom, AMD, Palantir And Cerebras Face A Yield Test

Friday’s open looked shaky for U.S. artificial intelligence shares, with higher Treasury yields and climbing oil prices threatening to derail the AI-driven surge that just sent Wall Street to fresh records. Nvidia, Microsoft, Broadcom, AMD, Palantir, and Cerebras—just public—are all in focus, but the market mood is notably harsher than on Thursday. Why now? Once more, AI is pulling much of the market’s weight. The S&P 500 and Nasdaq both finished at record highs on Thursday. Nvidia climbed 4.4% after U.S. officials approved H200 chip sales to certain Chinese companies. Over in IPO action, Cerebras soared 68.2% during its debut session.
15 May 2026
······
Rackspace Stock Jumps 26% As AMD AI Deal Tests RXT Turnaround Story

Rackspace Stock Jumps 26% As AMD AI Deal Tests RXT Turnaround Story

Rackspace Technology Inc. surged 26.34% to end Thursday at $7.29, marking another big run as the San Antonio cloud-services player draws buyers with its artificial intelligence infrastructure narrative. Shares peaked at $7.65 before settling to $7.15 in late trading. Why’s this in focus now? Traders are giving Rackspace — long seen as a managed cloud outfit weighed down by debt — a fresh look, framing it as a potential AI infrastructure play for regulated clients. That’s a tight but current angle: finance, healthcare, and government firms are all shopping for AI setups they can actually audit, lock down, and fit within strict internal rules.
14 May 2026
·····
Palantir Stock Just Sank After a Blowout Quarter. Wall Street Is Finding the One Thing It Didn’t Like

Palantir Stock Just Sank After a Blowout Quarter. Wall Street Is Finding the One Thing It Didn’t Like

Palantir Technologies shares dropped 1.4% to $134.04 late Wednesday morning, deepening a selloff that’s followed its recent earnings release. That’s even with the data analytics and AI software firm delivering its strongest revenue growth yet as a public company and upping its full-year forecast. The stock finished Tuesday at $135.91. Palantir doesn’t have much margin for error here. Investors have pegged it as a top beneficiary of corporate and government AI budgets—yet that’s pushed the stock to a level where investors expect almost flawless execution.
6 May 2026
···
Palantir Stock (PLTR) Drops After Record Q1: Wall Street Is Stuck on One Number

Palantir Stock (PLTR) Drops After Record Q1: Wall Street Is Stuck on One Number

Palantir Technologies shares slumped 6.9% to $135.91 on Tuesday, as Wall Street punished the stock in spite of record first-quarter revenue, stronger profit, and a bumped-up 2026 forecast. Investors zeroed in on valuation concerns and a U.S. commercial sales number that missed the mark. The stock was still under pressure headed into Wednesday's U.S. premarket. The stakes are high right now: Palantir’s stock remains one of the purest enterprise AI plays in public markets. The company sits at a market cap near $349 billion, and shares fetch around 153 times earnings. That multiple doesn’t leave much tolerance for quarterly results that impress but don’t hit every mark.
6 May 2026
··
Palantir Technologies Stock Just Got an AI Forecast Boost. Why Investors Still Paused

Palantir Technologies Stock Just Got an AI Forecast Boost. Why Investors Still Paused

Palantir Technologies bumped up its 2026 revenue outlook following an 85% surge in first-quarter sales, as US demand for its AI software keeps climbing. Shares showed just a slight premarket gain, last trading at $146.03—about 1.4% above Monday’s close. The distinction is getting sharper—investors are favoring AI firms with real revenue over those pitching future promise. Palantir’s latest results handed bulls solid ammunition: rapid growth, fat margins, strong cash generation. Detractors, though, stuck to their usual arguments about the stock’s valuation and warned that upstart AI players might replicate some of Palantir’s approach.
5 May 2026
···
Dow Drops 557 Points as Oil Shock Hits US Stocks; Palantir Slides After Hours

Dow Drops 557 Points as Oil Shock Hits US Stocks; Palantir Slides After Hours

Wall Street ended Monday in the red, with a renewed oil shock linked to the Strait of Hormuz knocking the S&P 500 off its record and pushing the Dow down by more than 550 points. The Dow Jones Industrial Average dropped 1.13% to 48,941.90, according to LSEG. The S&P 500 retreated 0.41% to 7,200.75, while the Nasdaq Composite slipped 0.19% to 25,067.80. This one landed hard on a market with almost no buffer. The S&P 500 and Nasdaq were coming off all-time highs Friday—lifted by upbeat earnings and falling oil. Analysts, for their part, had just bumped up their Q1 profit growth forecast for S&P 500 companies to 27.8%, according to LSEG I/B/E/S data cited by Reuters.
5 May 2026
··
U.S. Stock Market Week Ahead: Jobs Report, Fed Split and Earnings Could Test Wall Street’s Record Run

U.S. Stock Market Week Ahead: Jobs Report, Fed Split and Earnings Could Test Wall Street’s Record Run

NEW YORK, May 3, 2026, 1:03 PM EDT Wall Street heads into the week of May 4 with both the S&P 500 and Nasdaq sitting at fresh record closes, leaving Friday’s April payrolls report and a fresh batch of earnings set to challenge a rally driven by tech outperformance. On Friday, the S&P 500 and Nasdaq closed higher, but the Dow edged down after a flood of earnings reports helped investors set aside concerns about oil prices, at least for now.
3 May 2026
·····
Palantir Stock Faces a May 4 Earnings Test as Wall Street Sees Upside but Political Heat Builds

Palantir Stock Faces a May 4 Earnings Test as Wall Street Sees Upside but Political Heat Builds

Palantir Technologies faces its May 4 earnings with analysts divided—some see strong AI-fueled growth ahead, others remain cautious given valuation and political overhangs. Ahead of the U.S. market open on Monday, Palantir shares showed a 1.06% gain at $143.09. Super Micro Computer, meanwhile, was quoted at $29.08, up 8.65%. The timing is key: Palantir now stands as one of the market’s purest plays on the AI software story. The company plans to report first-quarter earnings after U.S. markets close on May 4, followed by a webcast set for 5 p.m. ET. Investors will get an updated read on appetite for its Artificial Intelligence Platform, or AIP, which helps both companies and governments leverage AI on their data.
27 April 2026
···
1 2 3 … 13

Stock Market Today

  • Kymera Therapeutics (KYMR) up 51% YTD as atopic dermatitis drug hits milestones
    July 1, 2026, 2:57 PM EDT. Kymera Therapeutics (KYMR) is up nearly 51% this year, way ahead of the sector's 6.4%. The stock's gain is tied to progress on KT-621, an oral STAT6 degrader for atopic dermatitis and asthma. Kymera wrapped phase IIb enrollment in the BROADEN2 AD trial six months early, aiming to have the pivotal readout by late 2026. Earlier, phase Ib data showed strong STAT6 knockdown and safety. The FDA put KT-621 on Fast Track for moderate-to-severe AD and eosinophilic asthma. Separately, trials for KT-485, in partnership with Sanofi, led to a $20 million milestone, and Kymera is still developing KT-579. Its alliances with Sanofi and Gilead are part of the company's long-term plans.
Go toTop